| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $25K | -26.8% |
| Cost of Revenue | $15K | — |
| Gross Profit | $10K | -71.9% |
| R&D Expense | $44K | — |
| SG&A Expense | $324K | +123.1% |
| Operating Income | -$1.0M | -57.5% |
| Pre-tax Income | -$1.0M | -57.0% |
| Net Income | -$1.0M | -57.0% |
| EPS (Basic) | -$0.01 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $29K | — |
| Current Assets | $39K | -78.9% |
| Total Assets | $39K | -78.9% |
| Current Liabilities | $339K | +42.9% |
| Total Liabilities | $339K | +42.9% |
| Stockholders' Equity | -$300K | -475.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$927K | -185.2% |
| Financing Cash Flow | $753K | +50.7% |
| — |
| EPS (Diluted) | -$0.01 | — |